Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer (Q73203626)
Jump to navigation
Jump to search
scientific article published on 01 January 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer |
scientific article published on 01 January 1997 |
Statements
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer (English)
S Fetscher
W Brugger
R Engelhardt
L Kanz
J Hasse
H Frommhold
M Wenger
W Lange